Related Experiment Video

Updated: May 15, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Combining Notch inhibition with current therapies for breast cancer treatment

Keith Brennan1, Robert B Clarke

  • 1Wellcome Trust Centre for Cell-Matrix Research and Manchester Breast Centre, Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

Therapeutic Advances in Medical Oncology
|January 17, 2013
PubMed

Insights

Targeting Notch signalling shows promise for breast cancer treatment. Combining Notch pathway inhibitors with existing therapies may offer the most effective strategy for improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signalling

Background:

  • Notch signalling pathway components are frequently altered in breast cancer.
  • Notch signalling influences key cellular processes in tumour initiation and progression.
  • Emerging evidence highlights the therapeutic potential of targeting Notch in breast cancer.

Purpose of the Study:

  • To review the role of Notch signalling in breast cancer.
  • To discuss the clinical development of Notch pathway inhibitors.
  • To explore optimal treatment strategies involving Notch inhibition.

Main Methods:

  • Literature review of studies on Notch signalling in breast cancer.
  • Analysis of preclinical and clinical data for Notch inhibitors.
  • Synthesis of current research on combination therapies.

Main Results:

  • Notch pathway inhibitors are advancing into early clinical trials.
  • Altered Notch signalling is implicated in breast cancer development and metastasis.
  • Combination strategies involving Notch inhibitors and conventional therapies show significant potential.

Conclusions:

  • Targeting Notch signalling is a promising avenue for breast cancer treatment.
  • The optimal use of Notch inhibitors likely involves combination therapies.
  • Further research is needed to define the most effective treatment regimens.
Keywords:
NotchNotch inhibitorsbreast cancercombination therapy

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...